US2004235117A1PendingUtilityA1

Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins

Priority: Dec 30, 1999Filed: Jun 18, 2004Published: Nov 25, 2004
Est. expiryDec 30, 2019(expired)· nominal 20-yr term from priority
A61P 43/00A61P 37/06A61P 37/00A61P 37/04A61P 31/14A61P 31/12A61P 31/04A61P 31/18A61P 35/00A61P 29/00A61P 31/00A61P 31/16A61P 33/06C07K 2319/00G01N 2333/70575C07K 14/4702C07K 19/00C07K 14/70575C07K 2319/32C07K 14/472C07K 14/525C07K 2319/21C07K 2319/43C07K 2319/41A61K 38/00C07K 2319/40C07K 2319/73G01N 33/6863C12N 15/62A61P 5/00C07K 14/435
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to oligomers of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins. Said oligomers are characterized in that the recombinant fusion proteins have at least one component A and at least one component B, whereby component A contains a protein or a protein segment with a biological function, in particular with a ligand function for antibodies, for soluble or membranous signal molecules, for receptors or an antibody, or an antibody segment, and component B contains a protein or a protein segment which dimerizes or oligomerizes the dimer, trimer, quatromer or pentamer of the recombinant fusion protein, without the action of third-party molecules. The invention also relates to the use of dimers or oligomers of this type for producing a medicament, to the fusion proteins which cluster in dimers or oligomers and to their DNA sequence and expression vectors or host cells comprising this DNA sequence.

Claims

exact text as granted — not AI-modified
1 - 28 . (canceled)  
     
     
         29 . A fusion protein comprising the extracellular domain of a receptor of the TNF family, fused to an oligomerising domain of a protein selected from the group consisting of the cartilage oligomeric protein (COMP) and the cartilage matrix protein (CMP).  
     
     
         30 . The fusion protein of  claim 29 , wherein the receptor of the TNF family is selected from the group consisting of Fas, TRAIL-R1, TRAIL-R2, TRAILR-3, TNF-R1 and CD40.  
     
     
         31 . A pentamer of a fusion protein comprising the extracellular domain of a receptor of the TNF family, fused to an oligomerising domain of the cartilage oligomeric protein (COMP).  
     
     
         32 . The pentamer of  claim 31 , wherein the receptor of the TNF family is Fas.  
     
     
         33 . The pentamer of  claim 31 , wherein the receptor of the TNF family is CD40.  
     
     
         34 . A DNA sequence encoding the fusion protein according to  claim 29 .  
     
     
         35 . An expression vector containing the DNA sequence according to  claim 34 .  
     
     
         36 . A host cell transfected with an expression vector according to  claim 35.

Join the waitlist — get patent alerts

Track US2004235117A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.